In Italy, the use of albumin is recommended by national guidelines to treat or prevent severe complications of cirrhosis such as circulatory dysfunction after LVP, renal failure caused by SBP, and treatment of HRS along with vasoconstrictors. This evidence concerns the gene ALB and acute kidney injury.